期刊文献+

肺癌组织中低氧诱导因子1α表达与肿瘤耐药关系的研究 被引量:6

Relation between tumor drug resistance and expression of hypoxia induced factor 1α in lung carcinoma
下载PDF
导出
摘要 目的:探讨肺癌组织中低氧诱导因子1α(hypoxia induced factor1α,HIF-1α)多药耐药相关蛋白(multidrug resistance related pro-tein,MRP)和谷胱甘肽S转移酶-π(GLU Ta-thione S-transferase pi,GST-π)的表达及其相关性。方法:采用免疫组织化学方法检测42例肺癌组织中HIF-1α、MRP和GST-π的表达。结果:42例肺癌组织中HIF-1α阳性表达35例(83·3%);MRP阳性表达24例(57·1%);GST-π阳性表达23例(54·8%)。HIF-1α表达与GST-π蛋白表达呈正相关,χ2=7·69,P=0·0058;HIF-1α表达与MRP表达无相关性,χ2=1·58,P=0·2219。肺癌组织T3、T4组与T1、T2组相比,HIF-1α、MRP和GST-π高表达率均明显增加,χ2值分别为5·47、5·80和6·77,P值分别为0·0208、0·0188和0·0094。肺癌组织有淋巴结转移组与无淋巴结转移组相比,HIF-1α、MRP和GST-π高表达率均明显增加,χ2值分别为6·19、4·97和6·31,P值分别为0·0140、0·0251和0·0103。结论:HIF-1α可能对GST-π的表达起上调作用。HIF-1α、MRP和GST-π高表达与肺癌的浸润程度和淋巴结转移有关。 OBJECTIVE: To investigate the expression and relation of hypoxia induced factor 1α (HIF-1α) , multidrug resistance related protein(MRP)and GLUTathione S-transferase pi (GST-π) in lung carcinoma. METHODS: The expression of HIF-1α, MRP and GST-π were tested by immunohistochemical method in 42 cases of lung cancer specimens. RESULTES: In 42 cases of lung carcinoma specimens, 35 cases showed positive staining of HIF-1α protein (83.3%); 24 cases showed positive staining of MRP protein (57. 1%); and 23 cases of GST-π protein (54.8%). There was significant positive correlation between the expression of HIF-1α and GST-π(Х^2 = 7.69, P= 0. 005 8), but there was no significant correlation between HIF-1αand MRP( Х^2=1.58, P=0.221 9). Compared with the expression of HIF-1α, MRP and GST-π in lung carcinoma tissues of T1 and T2 group, there was markedly increased in the T3 and T4 group (P were 0. 020 8, 0. 018 8 and 0. 009 4 respectively). The expression of HIF-1α, MRP and GST-π with lymphatic metastasis in lung carcinoma was significantly higher than those without lymphatic metastasis (P were 0. 014, 0. 025 1, and 0. 010 3 respectively). CONCLUSIONS: HIF-1α might upregulate the expression of GST-π. High-level expression of HIF1α, MRP and GST-π is associated with invasion degree and lymphatic metastasis of lung carcinoma.
出处 《中华肿瘤防治杂志》 CAS 2008年第7期526-529,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 肺肿瘤 多药耐药相关蛋白质类 谷胱甘肽转移酶 lung neoplasms multidrug resistance-associated proteins glutathione transferase
  • 相关文献

参考文献11

  • 1Semenza G L.HIF-1:mediator of physiological and pathophysiological responses to hypoxia[J].J Appl Physiol,2000,88(4):1474-1480.
  • 2Semenza G L.02-regulated gene expression:transcriptional control of cardiorespiratory-hysiology by HIF-1[J].J Appl Physiol,2004,96(3):1173-1177.
  • 3王艳芬,丁永玲,王东林,施公胜,周晓明,李家驭.人脑胶质瘤组织HIF-1α和COX-2及CD105蛋白表达与临床病理学关系的研究[J].中华肿瘤防治杂志,2007,14(19):1458-1461. 被引量:6
  • 4Sobin L H,Wittekind C.UICC TNM classification of malignanttumous[M].5thed.NewYork:Wiley Liss,1997:93-97.
  • 5Yeh J J,Hsu N Y,Hsu W H,et al.Comparison of chemotherapy response with P-glycoprotein,multidrug resistance-related protein-1,and lung resistance-related protein expression in untreated small cell lung cancer[J].Lung,2005,183(3):177-183.
  • 6张咏梅,王朝卿,孙建锁,宋光耀.非小细胞肺癌组织中MRP1 mRNA和GST-π mRNA的表达及意义[J].中华肿瘤防治杂志,2007,14(12):913-916. 被引量:9
  • 7Gajra A,Vajpayee N,Wade M,et al.Expression of the glutathione-S-transferaseπ(GST-π)protein correlates with survival in patients with stage l non-small cell lung cancer(NSCLC)[J].ASC0 Meeting Abstracts,2007,25(185):21065.
  • 8Lee J W,Bae S H,Jeong J W,et al.Hypoxia-inducible factor(HIF-1)alpha:its protein stability and biological functions[J].Exp Mol Med,2004,36(1):1-12.
  • 9Chen C,Pore N,Behrooz A,et al.Regulation of glut l mRNA by hypoxia-inducible factor-1.Interaction between H-ras and hypoxia[J].J Bio Chem,2001,276(12):9519-9525.
  • 10王永来,刘彩刚,陈双,黄铄.HIF-1α与VEGF在子宫内膜癌组织血管生成中的作用[J].中华肿瘤防治杂志,2007,14(15):1156-1158. 被引量:14

二级参考文献33

  • 1管晓翔,陈龙邦.环氧化酶-2在肿瘤发生中的作用机制[J].肿瘤防治杂志,2004,11(5):543-545. 被引量:5
  • 2董伦,浦佩玉,王虎,王广秀,康春生,焦德让.星形细胞肿瘤表皮生长因子受体与p53基因的异常表达[J].中华病理学杂志,2006,35(4):232-236. 被引量:10
  • 3邓清,田夫,沈淑英,李密,李明忠.大肠癌组织中Cox-2和FasL的表达及意义[J].中华肿瘤防治杂志,2006,13(1):48-50. 被引量:6
  • 4Sobin L H,Wittekind C.UICC TNM classification of malignant tumous[M].5thed.NewYork:Wiley Liss,1997:93-97.
  • 5Sorenson S,Glimelius B,Nygren P.A systematic over view of chemotherapy effects in non-small cell lung cancer[J].Acta Oncol,2001,40(2-3):327-339.
  • 6Kamimoto Y,Gatmaitan Z,Hsu J,et al.The function of GP170,the multidxug resistance gene product,in rat liver canaliculax membrane vesicles[J].J Biol Chem,1989,264(20):11693-11698.
  • 7Ishikawa T,Li Z S,Lu Y P,et al.The GS-X pump in plant,yeast,and animal cells:structure,function,and gene expression[J].Biosci Rep,1997,7(2):189-207.
  • 8Jedlitschky G,Keppler D.Transport of leukotriene C4 and structurally related conjugates[J].Vitam Horm,2002,64:153-184.
  • 9Kessel D.Exploring multidrug resistance using rhodamine 123[J].Cancer Commun,1989,1 (3):145-149.
  • 10Youg L C,Campling B G,Cole S P,et al.Multidrug resistance proterns MRP3,MRP1and MRP2 in lung cancer[J].Clin Cancer Res,2001,7(6):1798-1804.

共引文献26

同被引文献114

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部